Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2years on automated insulin delivery system
AimsThis study investigates the influence of the automated insulin delivery system (AID) on glycaemic control in children and adolescents with type 1 diabetes (T1D) who do not reach optimal glycaemic control with traditional treatment options.Materials and MethodsAll the patients aged 7 to 16 years...
Gespeichert in:
Veröffentlicht in: | Diabetes, obesity & metabolism obesity & metabolism, 2025-01, Vol.27 (1), p.134-142 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 142 |
---|---|
container_issue | 1 |
container_start_page | 134 |
container_title | Diabetes, obesity & metabolism |
container_volume | 27 |
creator | Kiilavuori, Maaria Varimo, Tero Anna‐Kaisa Tuomaala Mari‐Anne Pulkkinen |
description | AimsThis study investigates the influence of the automated insulin delivery system (AID) on glycaemic control in children and adolescents with type 1 diabetes (T1D) who do not reach optimal glycaemic control with traditional treatment options.Materials and MethodsAll the patients aged 7 to 16 years with T1D who initiated the AID system between 24 October 2020 and 5 January 2022 in the Helsinki University Hospital and had haemoglobin A1C (HbA1c) levels above 53 mmol/mol/7.0% (N = 79) were included. Time in tight range (TITR), time in range (TIR), HbA1c, mean sensor glucose (SG) value, time below range (TBR) and SG coefficient of variance (CV) were measured at 0, 3, 12 and 24 months. The changes in the outcome measures between the time points were included in the analyses, and statistically significant level was p‐value |
doi_str_mv | 10.1111/dom.15992 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_3140720001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3140720001</sourcerecordid><originalsourceid>FETCH-proquest_journals_31407200013</originalsourceid><addsrcrecordid>eNqNj01OwzAUhC1EJQp0wQ2exDrFP6Ft1hWIA7Cv3PqFuHLs4PdclBNwbSzEAZjNjDSjTxohHpRcq6onl8a1eu46fSWWqt2YRhm9uf7Nutl1Ut-IW6KzlLI1u-1SfO8HH1zGCDY6sC4FpBNGhi_PA1A5pon9aAOcUuScAqQeeJ4QFDhvj8hI4McppwuCK9nHD-ABofeZGPSMNhOkCi-cRsvowEcqwUdwGPwF8ww0E-N4Lxa9DYSrP78Tj68v7_u3pqI_CxIfzqnkWKuDUa3c6vpAmf-tfgCmZ1lV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3140720001</pqid></control><display><type>article</type><title>Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2years on automated insulin delivery system</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kiilavuori, Maaria ; Varimo, Tero ; Anna‐Kaisa Tuomaala ; Mari‐Anne Pulkkinen</creator><creatorcontrib>Kiilavuori, Maaria ; Varimo, Tero ; Anna‐Kaisa Tuomaala ; Mari‐Anne Pulkkinen</creatorcontrib><description>AimsThis study investigates the influence of the automated insulin delivery system (AID) on glycaemic control in children and adolescents with type 1 diabetes (T1D) who do not reach optimal glycaemic control with traditional treatment options.Materials and MethodsAll the patients aged 7 to 16 years with T1D who initiated the AID system between 24 October 2020 and 5 January 2022 in the Helsinki University Hospital and had haemoglobin A1C (HbA1c) levels above 53 mmol/mol/7.0% (N = 79) were included. Time in tight range (TITR), time in range (TIR), HbA1c, mean sensor glucose (SG) value, time below range (TBR) and SG coefficient of variance (CV) were measured at 0, 3, 12 and 24 months. The changes in the outcome measures between the time points were included in the analyses, and statistically significant level was p‐value <0.01.ResultsAfter the initiation of AID, glycaemic control improved, and the effect lasted throughout the study period. Between 0 and 3 months, TITR and TIR increased (mean 11.7% [10.6], mean 18.1% [standard deviation [SD] 13.7], p < 0.001), whereas HbA1c and mean SG values decreased significantly (−8.3 mmol/mol [8.7]/−2.9% [2.9], p < 0.001, −1.8 mmol/L [1.7], p < 0.001). These effects were sustainable and were still visible at 12 and 24 months.ConclusionsGlycaemic control in patients not reaching treatment goals improved significantly after the initiation of the AID system, and the favourable effect lasted throughout the follow‐up. AID treatment could be an option for also those paediatric patients with T1D who do not have good skills in diabetes management.</description><identifier>ISSN: 1462-8902</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/dom.15992</identifier><language>eng</language><publisher>Oxford: Wiley Subscription Services, Inc</publisher><subject>Automation ; Diabetes ; Diabetes mellitus (insulin dependent) ; Disease management ; Hemoglobin ; Insulin ; Patients ; Pediatrics ; Statistical analysis</subject><ispartof>Diabetes, obesity & metabolism, 2025-01, Vol.27 (1), p.134-142</ispartof><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kiilavuori, Maaria</creatorcontrib><creatorcontrib>Varimo, Tero</creatorcontrib><creatorcontrib>Anna‐Kaisa Tuomaala</creatorcontrib><creatorcontrib>Mari‐Anne Pulkkinen</creatorcontrib><title>Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2years on automated insulin delivery system</title><title>Diabetes, obesity & metabolism</title><description>AimsThis study investigates the influence of the automated insulin delivery system (AID) on glycaemic control in children and adolescents with type 1 diabetes (T1D) who do not reach optimal glycaemic control with traditional treatment options.Materials and MethodsAll the patients aged 7 to 16 years with T1D who initiated the AID system between 24 October 2020 and 5 January 2022 in the Helsinki University Hospital and had haemoglobin A1C (HbA1c) levels above 53 mmol/mol/7.0% (N = 79) were included. Time in tight range (TITR), time in range (TIR), HbA1c, mean sensor glucose (SG) value, time below range (TBR) and SG coefficient of variance (CV) were measured at 0, 3, 12 and 24 months. The changes in the outcome measures between the time points were included in the analyses, and statistically significant level was p‐value <0.01.ResultsAfter the initiation of AID, glycaemic control improved, and the effect lasted throughout the study period. Between 0 and 3 months, TITR and TIR increased (mean 11.7% [10.6], mean 18.1% [standard deviation [SD] 13.7], p < 0.001), whereas HbA1c and mean SG values decreased significantly (−8.3 mmol/mol [8.7]/−2.9% [2.9], p < 0.001, −1.8 mmol/L [1.7], p < 0.001). These effects were sustainable and were still visible at 12 and 24 months.ConclusionsGlycaemic control in patients not reaching treatment goals improved significantly after the initiation of the AID system, and the favourable effect lasted throughout the follow‐up. AID treatment could be an option for also those paediatric patients with T1D who do not have good skills in diabetes management.</description><subject>Automation</subject><subject>Diabetes</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Disease management</subject><subject>Hemoglobin</subject><subject>Insulin</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Statistical analysis</subject><issn>1462-8902</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNqNj01OwzAUhC1EJQp0wQ2exDrFP6Ft1hWIA7Cv3PqFuHLs4PdclBNwbSzEAZjNjDSjTxohHpRcq6onl8a1eu46fSWWqt2YRhm9uf7Nutl1Ut-IW6KzlLI1u-1SfO8HH1zGCDY6sC4FpBNGhi_PA1A5pon9aAOcUuScAqQeeJ4QFDhvj8hI4McppwuCK9nHD-ABofeZGPSMNhOkCi-cRsvowEcqwUdwGPwF8ww0E-N4Lxa9DYSrP78Tj68v7_u3pqI_CxIfzqnkWKuDUa3c6vpAmf-tfgCmZ1lV</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>Kiilavuori, Maaria</creator><creator>Varimo, Tero</creator><creator>Anna‐Kaisa Tuomaala</creator><creator>Mari‐Anne Pulkkinen</creator><general>Wiley Subscription Services, Inc</general><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20250101</creationdate><title>Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2years on automated insulin delivery system</title><author>Kiilavuori, Maaria ; Varimo, Tero ; Anna‐Kaisa Tuomaala ; Mari‐Anne Pulkkinen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_31407200013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Automation</topic><topic>Diabetes</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Disease management</topic><topic>Hemoglobin</topic><topic>Insulin</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kiilavuori, Maaria</creatorcontrib><creatorcontrib>Varimo, Tero</creatorcontrib><creatorcontrib>Anna‐Kaisa Tuomaala</creatorcontrib><creatorcontrib>Mari‐Anne Pulkkinen</creatorcontrib><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Diabetes, obesity & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kiilavuori, Maaria</au><au>Varimo, Tero</au><au>Anna‐Kaisa Tuomaala</au><au>Mari‐Anne Pulkkinen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2years on automated insulin delivery system</atitle><jtitle>Diabetes, obesity & metabolism</jtitle><date>2025-01-01</date><risdate>2025</risdate><volume>27</volume><issue>1</issue><spage>134</spage><epage>142</epage><pages>134-142</pages><issn>1462-8902</issn><eissn>1463-1326</eissn><abstract>AimsThis study investigates the influence of the automated insulin delivery system (AID) on glycaemic control in children and adolescents with type 1 diabetes (T1D) who do not reach optimal glycaemic control with traditional treatment options.Materials and MethodsAll the patients aged 7 to 16 years with T1D who initiated the AID system between 24 October 2020 and 5 January 2022 in the Helsinki University Hospital and had haemoglobin A1C (HbA1c) levels above 53 mmol/mol/7.0% (N = 79) were included. Time in tight range (TITR), time in range (TIR), HbA1c, mean sensor glucose (SG) value, time below range (TBR) and SG coefficient of variance (CV) were measured at 0, 3, 12 and 24 months. The changes in the outcome measures between the time points were included in the analyses, and statistically significant level was p‐value <0.01.ResultsAfter the initiation of AID, glycaemic control improved, and the effect lasted throughout the study period. Between 0 and 3 months, TITR and TIR increased (mean 11.7% [10.6], mean 18.1% [standard deviation [SD] 13.7], p < 0.001), whereas HbA1c and mean SG values decreased significantly (−8.3 mmol/mol [8.7]/−2.9% [2.9], p < 0.001, −1.8 mmol/L [1.7], p < 0.001). These effects were sustainable and were still visible at 12 and 24 months.ConclusionsGlycaemic control in patients not reaching treatment goals improved significantly after the initiation of the AID system, and the favourable effect lasted throughout the follow‐up. AID treatment could be an option for also those paediatric patients with T1D who do not have good skills in diabetes management.</abstract><cop>Oxford</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/dom.15992</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-8902 |
ispartof | Diabetes, obesity & metabolism, 2025-01, Vol.27 (1), p.134-142 |
issn | 1462-8902 1463-1326 |
language | eng |
recordid | cdi_proquest_journals_3140720001 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Automation Diabetes Diabetes mellitus (insulin dependent) Disease management Hemoglobin Insulin Patients Pediatrics Statistical analysis |
title | Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2years on automated insulin delivery system |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A10%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Children%20and%20adolescent%20with%20suboptimal%20control%20of%20type%201%20diabetes%20improve%20during%20the%20first%202years%20on%20automated%20insulin%20delivery%20system&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Kiilavuori,%20Maaria&rft.date=2025-01-01&rft.volume=27&rft.issue=1&rft.spage=134&rft.epage=142&rft.pages=134-142&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/dom.15992&rft_dat=%3Cproquest%3E3140720001%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3140720001&rft_id=info:pmid/&rfr_iscdi=true |